Lucas’ Papaw Ointment

TGA

Consumer Level Recall – Potential microbial contamination of certain batches

Lucas’ Papaw Remedies is recalling several batches of Lucas’ Papaw Ointment (AUST L 13397) due to microbial contamination. The affected products come in 15g, 75g and 200g sizes.

The affected batch numbers are:

Product SizesBatch NumberExpiry
15g00522D22April 2025
00822E25May 2025
00822E26May 2025
00822E27May 2025
00822F01Jun 2025
00822F03Jun 2025
00822F06Jun 2025
00822E31May 2025
75g00522E04May 2025
00522E05May 2025
200g00822E30May 2025

Lucas’ Papaw Ointment is a topical ointment used to assist in the treatment of minor skin wounds, as well as skin dryness and chafing.

What should I do?

If you have a container of Lucas Papaw Ointment, check its batch number.

Batch numbers are on:

  • the ‘crimp’; at the top of the 15g tube
  • the bottom of the 75g and 200g containers.

If your ointment is from the affected batches, you should immediately stop using it.

Return it to the place of purchase for a refund or contact Lucas’; Papaw Remedies Customer Service on 1800 861 852.

No other batches or other Lucas’; Papaw Remedies products are being recalled at this time.

What is the problem?

Microbiological contamination was found in the above batches of Lucas’; Papaw Ointment.

The microorganisms have been identified as Aspergillus tubingensis, Sordaria humana, Penicillium paneum and Paenibacillus glucanolyticus.

What are the risks?

These moulds and bacteria pose minimal risk to the general population. There is a remote risk that individuals who are immunocompromised could become ill if they are exposed to these organisms.

Reporting problems

Consumers and health professionals are encouraged to report problems with medicines or vaccines. Your report will contribute to the TGA’s monitoring of these products.

The TGA cannot give advice about an individual’s medical condition. You are strongly encouraged to talk with a health professional if you are concerned about a possible adverse event associated with a medicine or vaccine.

/Public Release. This material from the originating organization/author(s) may be of a point-in-time nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s).View in full here.